Pregnancy outcome and fibrinolytic, endothelial and coagulation markers in women undergoing uterine artery Doppler screening at 23 weeks

Journal of Thrombosis and Haemostasis

Volumn 7, Issue 6, 2009, Pages 955-961

  Hunt, Beverley J ^a,e   Missfelder Lobos, H ^b   Parra Cordero, M ^c   Fletcher, O ^d   Parmar, K ^a   Lefkou, E ^a   Lees, C C ^b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Endothelium; Fibrinolysis; Pre eclampsia; Pregnancy; Uterine artery Doppler

Indexed keywords

ALPHA 2 ANTIPLASMIN; D DIMER; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; FEMALE; FIBRINOLYSIS; GESTATIONAL AGE; HUMAN; IMAGE DISPLAY; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SECOND TRIMESTER PREGNANCY; UTERINE ARTERY;

ADOLESCENT; ADULT; ARTERIES; BIOLOGICAL MARKERS; BLOOD COAGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; HUMANS; PREGNANCY; PREGNANCY OUTCOME; ULTRASONOGRAPHY, DOPPLER; UTERUS; YOUNG ADULT;

EID: 65849304182     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03344.x     Document Type: Article

References (35)

1. Roberts JM, Gammill HS. Preeclampsia: Recent insights. Hypertension 2005; 46: 1243-9.
2. Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA 2002; 287: 3183-6.
3. Poon LC, Kametas NA, Pandeva I, Valencia C, Nicolaides KH. Mean arterial pressure at 11(+0) to 13(+6) weeks in the prediction of preeclampsia. Hypertension 2008; 51: 1027-33.
4. Sibai BM, Ewell M, Levine RJ, Klebanoff MA, Esterlitz J, Catalano PM, Goldenberg RL, Joffe G. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 1997; 177: 1003-10.
5. Eskenazi B, Fenster L, Sidney S, Elkin EP. Fetal growth retardation in infants of multiparous and nulliparous women with preeclampsia. Am J Obstet Gynecol 1993; 169: 1112-18.
6. Goldenberg RL, Rouse DJ. Prevention of premature birth. N Engl J Med 1998; 339: 313-20.
7. Yu CK, Smith GC, Papageorghiou AT, Cacho AM, Nicolaides KH. An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. Am J Obstet Gynecol 2005; 193: 429-36.
8. Campbell S, Diaz-Recasens J, Griffin DR, Cohen-Overbeek TE, Pearce JM, Willson K, Teague MJ. New doppler technique for assessing uteroplacental blood flow. Lancet 1983; 1: 675-7.
9. Papageorghiou AT, Yu CK, Bindra R, Pandis G, Nicolaides KH. Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23.weeks of gestation. Ultrasound Obstet Gynecol 2001; 18: 441-9.
10. Albaiges G, Missfelder-Lobos H, Lees C, Parra M, Nicolaides KH. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23. weeks' gestation. Obstet Gynecol 2000; 96: 559-64.
11. Parra M, Rodrigo R, Barja P, Bosco C, Fernandez V, Munoz H, Soto-Chacon E. Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction. Am J Obstet Gynecol 2005; 193: 1486-91.
12. Lees C, Parra M, Missfelder-Lobos H, Morgans A, Fletcher O, Nicolaides KH. Individualized risk assessment for adverse pregnancy outcome by uterine artery Doppler at 23.weeks. Obstet Gynecol 2001; 98: 369-73.
13. Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD. Pre-eclampsia and fetal growth restriction: How morphometrically different is the placenta? Placenta 2006; 27: 727-34.
14. Halligan A, Bonnar J, Sheppard B, Darling M, Walshe J. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br J Obstet Gynaecol 1994; 101: 488-92.
15. Sucak GT, Acar K, Sucak A, Kirazli S, Haznedar R. Increased global fibrinolytic capacity as a clue for activated fibrinolysis in pre-eclampsia. Blood Coagul Fibrinolysis 2006; 17: 347-52.
16. Loskutoff DJ, Sawdey M, Keeton M, Schneiderman J. Regulation of PAI-1 gene expression in.vivo. Thromb Haemost 1993; 70: 135-7.
17. Hunt BJ, Jurd KM. Endothelial cell activation. A central pathophysiological process. BMJ 1998; 316: 1328-9.
18. Reith A, Booth NA, Moore NR, Cruickshank DJ, Bennett B. Plasminogen activator inhibitors (PAI-1 and PAI-2) in normal pregnancies, pre-eclampsia and hydatidiform mole. Br J Obstet Gynaecol 1993; 100: 370-4.
19. Estelles A, Gilabert J, Grancha S, Yamamoto K, Thinnes T, Espana F, Aznar J, Loskutoff DJ. Abnormal expression of type.1 plasminogen activator inhibitor and tissue factor in severe preeclampsia. Thromb Haemost 1998; 79: 500-8.
20. Yudkin PL, Aboualfa M, Eyre JA, Redman CW, Wilkinson AR. New birthweight and head circumference centiles for gestational ages 24 to 42.weeks. Early Hum Dev 1987; 15: 45-52.
21. Cuzick J. Wilcoxon-type test for trend. Stat Med 1985; 4: 87-90.
22. Lam C, Lim KH, Karumanchi SA. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 2005; 46: 1077-85.
23. Catarino C, Rebelo I, Belo L, Rocha S, Castro EB, Patricio B, Quintanilha A, Santos-Silva A. Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies. Thromb Res 2008; 123: 219-24.
24. Estelles A, Gilabert J, Keeton M, Eguchi Y, Aznar J, Grancha S, Espna F, Loskutoff DJ, Schleef RR. Altered expression of plasminogen activator inhibitor type.1 in placentas from pregnant women with preeclampsia and/ or intrauterine fetal growth retardation. Blood 1994; 84: 143-50.
25. Tanjung MT, Siddik HD, Hariman H, Koh SC. Coagulation and fibrinolysis in preeclampsia and neonates. Clin Appl Thromb Hemost 2005; 11: 467-73.
26. Chappell LC, Seed PT, Briley A, Kelly FJ, Hunt BJ, Charnock-Jones DS, Mallet AI, Poston L. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 2002; 187: 127-36.
27. Krauss T, Kuhn W, Lakoma C, Augustin HG. Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. Am J Obstet Gynecol 1997; 177: 443-9.
28. Clausen T, Djurovic S, Brosstad FR, Berg K, Henriksen T. Altered circulating levels of adhesion molecules at 18. weeks' gestation among women with eventual preeclampsia: Indicators of disturbed placentation in absence of evidence of endothelial dysfunction? Am J Obstet Gynecol 2000; 182: 321-5.
29. Airoldi L, Gaffuri B, Rossi G, Iurlaro E, Nozza A, Vigano P, Vignali M. Soluble intercellular adhesion molecule-1 serum profile in physiologic and preeclamptic pregnancy. Am J Reprod Immunol 1998; 39: 183-8.
30. Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest 1997; 99: 2152-64.
31. Labarrere CA, Ortiz MA, Sosa MJ, Campana GL, Wernicke M, Baldridge LA, Terry C, DiCarlo HL. Syncytiotrophoblast intercellular adhesion molecule-1 expression in placental villitis of unknown cause. Am J Obstet Gynecol 2005; 193: 483-8.
32. Esmon CT. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J 1995; 9: 946-55.
33. Bontis J, Vavilis D, Agorastos T, Zournatzi V, Konstantinidis T, Tagou K. Maternal plasma level of thrombomodulin is increased in mild preeclampsia. Eur J Obstet Gynecol Reprod Biol 1995; 60: 139-41.
34. Minakami H, Takahashi T, Izumi A, Tamada T. Increased levels of plasma thrombomodulin in preeclampsia. Gynecol Obstet Invest 1993; 36: 208-10.
35. Hsu CD, Copel JA, Hong SF, Chan DW. Thrombomodulin levels in preeclampsia, gestational hypertension, and chronic hypertension. Obstet Gynecol 1995; 86: 897-9.